Industry News
vivoPharm signs oncology partner for US
South Australia's vivoPharm has arranged to co-market primary patient-derived tumours owned by Berlin's EPO to US cancer drug researchers. [ + ]
Comment sought on "Enabling Technologies Roadmap"
The government is seeking comment on a new report covering the future of biotechnology and nanotechnology. [ + ]
Roche GS Junior Sequencing System used in research on personalised tumour treatment
The Center for Human Genetics and Laboratory Medicine Dr Klein and Dr Rost, and IMGM Laboratories, both located in Martinsried, Germany, have reported using the Roche GS Junior Benchtop System to sequence clinically relevant exons and identify genomic variations in solid tumours treated with an antibody-based medicine. [ + ]
UQ, industry partner for rheumatoid arthritis treatment
UniQuest spinoff and pharmaceutical R&D company Janssen-Cilag will combine resources to support the development of a rheumatoid arthritis treatment. [ + ]
Clinuvel trading at nine-month highs
Clinuvel Pharmaceuticals’ (ASX:CUV) cites positive trial results for SCENESSE as likely reason for 34.2% spike in stock price last week. [ + ]
Industry leaders to take part in annual industry position survey
AusBiotech is pleased to once again conduct the annual CEO Industry Position Survey 2012, this year proudly supported by Grant Thornton. [ + ]
Grant Watch
Our regular roundup of news and announcements in the wild world of scientific and health & medical research grants and funding. [ + ]
Technique enables in-depth study of two-dimensional electronic states within crystals
A new spectroscopy technique enables the investigation of two-dimensional electron states both at the surface and within crystals. [ + ]
Research identifies mutations underlying human hereditary hearing loss
Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche’s NimbleGen Custom Sequence Capture 385K array, to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary hearing loss. [ + ]
Bootylicious fly named after Beyonce
A new species of horse fly with a notably resplendent abdomen has been named after the American pop diva, Beyonce. [ + ]
Seismometers reveal Australia’s geological history
Researchers from The Australian National University have used the latest earthquake-measuring technology to image the tectonic plate beneath south-east Australia and reveal for the first time the continent’s geological building blocks. [ + ]
A new year, a new look and good news is rolling in already…
2011 ended on a high for the Australian biotechnology industry, and 2012 is already off to a strong start for the sector. [ + ]
Australian native plants found to have anti-microbial properties
A Queensland collaborative research programme has found common native Australian plums can extend the shelf life of meat products. [ + ]
Starpharma to advance with phase III studies for VivaGel
Phase III trials of VivaGel to commence shortly after receiving FDA agreement on study design in anticipation of application for regulatory approval. [ + ]
Bionomics scores deal worth up to US$345 million
Deal with US pharmaceutical company Ironwood to develop anti-anxiety compound BNC210 could be worth up to US$345 million for the Adelaide-based biotech. [ + ]
